Table 3.
Groups | Nonpractitioners (n = 34) | Combined-exercise training (n = 51) | ||||||
---|---|---|---|---|---|---|---|---|
Placebo (n = 15) | L-glutamine (n = 19) | Placebo (n = 26) | L-glutamine (n = 25) | |||||
Variables | Pre | Post | Pre | Post | Pre | Post | Pre | Post |
Peroxidase activity by GSH | r = 0.14, p = 0.64 | r = −0.37, p = 0.25 | r = −0.07, p = 0.79 | r = −0.12, p = 0.65 | r = 0.40, p = 0.04 | r = 0.04, p = 0.84 | r = 0.63, p = 0.002 | r = 0.69, p = 0.001 |
Peroxidase activity by GSSG | r = −0.41, p = 0.12 | r = −0.45, p = 0.19 | r = 0.09, p = 0.73 | r = 0.36, p = 0.18 | r = −0.06, p = 0.74 | r = 0.08, p = 0.71 | r = 0.25, p = 0.29 | r = −0.05, p = 0.81 |
Peroxidase activity by reducing power | r = −0.05, p = 0.84 | r = −0.20, p = 0.54 | r = −0.27, p = 0.32 | r = −0.41, p = 0.12 | r = 0.34, p = 0.08 | r = 0.01, p = 0.95 | r = −0.40, p = 0.09 | r = 0.25, p = 0.26 |
Peroxidase activity by uric acid | r = 0.46, p = 0.09 | r = −0.44, p = 0.19 | r = 0.01, p = 0.96 | r = −0.11, p = 0.70 | r = 0.15, p = 0.53 | r = 0.23, p = 0.34 | r = 0.31, p = 0.13 | r = 0.75, p = 0.0001 |
Uric acid by GSH | r = −0.01, p = 0.97 | r = 0.42, p = 0.12 | r = −0.33, p = 0.16 | r = −0.34, p = 0.15 | r = −0.05, p = 0.81 | r = −0.25, p = 0.24 | r = −0.12, p = 0.60 | r = 0.07, p = 0.77 |
Uric acid by GSSG | r = −0.17, p = 0.55 | r = −0.28, p = 0.34 | r = −0.18, p = 0.48 | r = −0.43, p = 0.06 | r = −0.34, p = 0.09 | r = −0.23, p = 0.29 | r = −0.22, p = 0.37 | r = 0.11, p = 0.62 |
Uric acid by reducing power | r = −0.19, p = 0.49 | r = 0.42, p = 0.12 | r = −0.07, p = 0.80 | r = 0.25, p = 0.31 | r = 0.1, p = 0.63 | r = 0.03, p = 0.90 | r = −0.11, p = 0.63 | r = 0.44, p = 0.04 |